Biotech RadarJobs updated

COMPANY

bioMerieux

biomerieux.com ↗

FDA-cleared device company

Profile checked Oct 10, 2026

Keywords: Sepsis Acute Kidney Injury Malaria Acute Respiratory Infections Respiratory Tract Infections Influenza-like Illness Mild Traumatic Brain Injury Septic Shock VAP - Ventilator Associated Pneumonia Dengue Chikungunya PULMONARY TUBERCULOSIS Active Tuberculosis Latent Tuberculosis Infection Non-Tuberculous Mycobacterial (NTM) Pneumonia Sepsis Newborn Immune Responses Severe Sepsis Ebola Virus Disease SPOTFIRE R/ST Diagnostic Test Subject management guided by NephroCheck® test Diagnostic Test: VIDAS® NEPHROCLEAR™ CCL14 Test

16Trials (company is sponsor)

Timeline

  1. Trial start Not phased (device or behavioral study): Clinical Assessment of Respiratory Events for Kids: Integrating Diagnostics and Stewardship source ↗
  2. Trial start Not phased (device or behavioral study): Impact of a Multiplex Respiratory PCR Test on Outcomes for Patients Presenting With Respiratory Illness in the Urgent Care Setting: A Hybrid-Effectiveness Quasi-Experimental Trial source ↗
  3. Trial start Not phased (device or behavioral study): VIDAS® TBI Real Life Performance in Subjects With Mild Traumatic Brain Injury (mTBI) source ↗
  4. Trial start —: LUNG INFECTION in ICU (LUNG-I3) source ↗
  5. Trial start —: VIDAS® NEPHROCLEAR Reference Interval Study source ↗
  6. Trial start —: VIDAS® NEPHROCLEAR Diagnostic Accuracy Study source ↗
  7. Trial start Not phased (device or behavioral study): Impact of Differential and Systematic Diagnosis of Dengue, Chikungunya and Malaria on Patient Management and Antibiotic Use in West Africa source ↗
  8. Trial start —: VIDAS Nephroclear (NCL) CCL14 - Sample Stability source ↗
  9. Trial start —: Validating the Use of Blood Transcriptomic Signatures for the Diagnosis of Active Pulmonary Tuberculosis source ↗
  10. Trial start Not phased (device or behavioral study): A Study Looking at the Use of Biomarkers to Provide Early Indication of Acute Kidney Injury in Patients With Sepsis (Limiting AKI Progression In Sepsis) source ↗
  11. Trial start —: Early Identification of SEPsis SIGNs in Emergency Department source ↗
  12. Trial start —: Performance Evaluation of the VIDAS TB-IGRA Assay. source ↗
  13. Trial start Not phased (device or behavioral study): Impact on PCT+ FilmArray RP2 Plus Use in LRTI Suspicion in Emergency Department source ↗
  14. Trial start —: Immune Dysfunction in Newborn Sepsis source ↗
  15. Trial start —: TRIAGE: TRIage of Sepsis At emerGency dEpartment source ↗
  16. Trial start —: Evaluation of the FilmArray BioThreat-E Test source ↗

Clinical trials (lead sponsor) 16

RecordTitlePhaseStatusStartPrimary completion
NCT07513519Impact of a Multiplex Respiratory PCR Test on Outcomes for Patients Presenting With Respiratory Illness in the Urgent Care Setting: A Hybrid-Effectiveness Quasi-Experimental TrialNot phased (device or behavioral study)RecruitingDec 22, 20252026-04 (estimated)
NCT07453914Clinical Assessment of Respiratory Events for Kids: Integrating Diagnostics and StewardshipNot phased (device or behavioral study)Not yet recruiting2026-032026-09 (estimated)
NCT06449183VIDAS® TBI Real Life Performance in Subjects With Mild Traumatic Brain Injury (mTBI)Not phased (device or behavioral study)CompletedMay 16, 2024Sep 3, 2025 (actual)
NCT04434209A Study Looking at the Use of Biomarkers to Provide Early Indication of Acute Kidney Injury in Patients With Sepsis (Limiting AKI Progression In Sepsis)Not phased (device or behavioral study)TerminatedJan 19, 2021Feb 14, 2022 (actual)
NCT06073834LUNG INFECTION in ICU (LUNG-I3)Not listedRecruitingDec 5, 20232026-04 (estimated)
NCT06257810Impact of Differential and Systematic Diagnosis of Dengue, Chikungunya and Malaria on Patient Management and Antibiotic Use in West AfricaNot phased (device or behavioral study)CompletedJun 1, 2023Jun 7, 2023 (actual)
NCT03840603Impact on PCT+ FilmArray RP2 Plus Use in LRTI Suspicion in Emergency DepartmentNot phased (device or behavioral study)CompletedSep 1, 2019Sep 1, 2019 (actual)
NCT04995406Validating the Use of Blood Transcriptomic Signatures for the Diagnosis of Active Pulmonary TuberculosisNot listedCompletedJan 3, 2022May 1, 2023 (actual)
NCT06036758VIDAS® NEPHROCLEAR Diagnostic Accuracy StudyNot listedCompletedJul 17, 2023Dec 28, 2023 (actual)
NCT06037109VIDAS® NEPHROCLEAR Reference Interval StudyNot listedCompletedJul 18, 2023Dec 28, 2023 (actual)
NCT05271617VIDAS Nephroclear (NCL) CCL14 - Sample StabilityNot listedCompletedMar 10, 2022Jul 31, 2023 (actual)
NCT04261621Early Identification of SEPsis SIGNs in Emergency DepartmentNot listedCompletedJul 6, 2020May 2, 2022 (actual)
NCT04048018Performance Evaluation of the VIDAS TB-IGRA Assay.Not listedCompletedDec 5, 2019Jun 30, 2021 (actual)
NCT03780712Immune Dysfunction in Newborn SepsisNot listedCompletedApr 17, 2016Mar 12, 2018 (actual)
NCT02739152TRIAGE: TRIage of Sepsis At emerGency dEpartmentNot listedCompleted2015-042018-01 (actual)
NCT02658331Evaluation of the FilmArray BioThreat-E TestNot listedCompleted2015-032015-07 (actual)
Feedback